Table 1.

Correlation of visfatin expression with clinicopathologic characteristics of breast cancer patients

VariablesItemVisfatinPa
LowHigh
n%n%
StageI/II4756.63643.40.091
III/IV836.41463.6
GradeI/II4155.43344.60.338
III1445.21754.8
Age, y≤503257.12442.90.296
502346.92653.1
BMI, kg/m2<243149.23250.80.425
≥242457.11842.9
Tumor size, cm<23164.61735.40.022
≥22442.13357.9
LN metastasis0–14657.53442.50.060
≥2936.01664.0
ERNegative1233.32466.70.005
Positive4362.32637.7
PRNegative1737.82862.20.009
Positive3863.32236.7
Her2/neuNegative3146.33653.70.096
Positive2463.21436.8
  • aP value was calculated by the χ2 test.